Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

Anti-VRK1 antibody [5D1] - N-terminal (ab171933)

Price and availability

254 630 ₸

Availability

Order now and get it on Tuesday March 02, 2021

Anti-VRK1 antibody [5D1] - N-terminal (ab171933)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Mouse monoclonal [5D1] to VRK1 - N-terminal
  • Suitable for: WB, ICC/IF
  • Knockout validated
  • Reacts with: Human
  • Isotype: IgG1

You may also be interested in

Product image
Anti-PD1 antibody [CAL15] (ab237727)
Product image
Anti-SERCA1 ATPase antibody [VE121G9] - BSA and Azide free (ab255956)
Product image
Anti-ICAM1 antibody - BSA and Azide free (Detector) (ab259646)
HRP Anti-alpha Lactalbumin antibody (ab112973)

Overview

  • Product name

    Anti-VRK1 antibody [5D1] - N-terminal
    See all VRK1 primary antibodies
  • Description

    Mouse monoclonal [5D1] to VRK1 - N-terminal
  • Host species

    Mouse
  • Tested Applications & Species

    Application Species
    ICC/IF
    Human
    WB
    Human
    See all applications and species data
  • Immunogen

    Synthetic peptide corresponding to Human VRK1 aa 1-19 (N terminal) (Cysteine residue).
    Sequence:

    MPRVKAAQAGRQSSAKRHL-C


    Database link: Q99986
    Run BLAST with BLAST the sequence with ExPASy Run BLAST with BLAST the sequence with NCBI
  • Positive control

    • WB: HEK293T, HeLa, TIG-1 and U2OS cell lysates. ICC/IF: interphase and metaphase HeLa cells.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
  • Storage buffer

    pH: 6
    Constituents: 50% PBS, 50% Glycerol (glycerin, glycerine)
  • Concentration information loading...
  • Clonality

    Monoclonal
  • Clone number

    5D1
  • Isotype

    IgG1
  • Light chain type

    kappa
  • Research areas

    • Cell Biology
    • Cell Cycle
    • Cell Cycle Inhibitors
    • p53
    • Signal Transduction
    • Protein Phosphorylation
    • Ser / Thr Kinases
    • Other Kinases
    • Epigenetics and Nuclear Signaling
    • Cell cycle
    • Cell Cycle Inhibitors
    • p53

Images

  • Western blot - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)
    Western blot - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)
    All lanes : Anti-VRK1 antibody [5D1] - N-terminal (ab171933) at 1/500 dilution

    Lane 1 : Wild-type HEK293T cell lysate
    Lane 2 : VRK1 knockout HEK293T cell lysate
    Lane 3 : HeLa cell lysate

    Lysates/proteins at 20 µg per lane.

    Secondary
    All lanes : Goat Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (ab216777) at 1/10000 dilution

    Predicted band size: 45 kDa
    Observed band size: 50 kDa
    why is the actual band size different from the predicted?



    Lanes 1-3: Merged signal (red and green). Green - ab171933 observed at 50 kDa. Red - loading control ab181602 observed at 36 kDa.

     ab171933 Anti-VRK1 antibody [5D1] - N-terminal was shown to specifically react with VRK1 in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266257 (knockout cell lysate ab258283) was used. Wild-type and VRK1 knockout samples were subjected to SDS-PAGE. ab171933 and Anti-GAPDH antibody[EPR16891] - Loading Control (ab181602) were incubated overnight at 4°C at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (ab216777) and Goat anti-Mouse IgG H&L (IRDye® 800CW) preadsorbed (ab216772) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

  • Immunocytochemistry/ Immunofluorescence - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)
    Immunocytochemistry/ Immunofluorescence - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)

    Immunofluorescent analysis of paraformaldehyde-fixed interphase HeLa cells labeling VRK1 with ab171933 at 1/100 dilution (center). DNA was stained with DAPI (left) and two images were merged (right; merge).

  • Western blot - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)
    Western blot - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)
    Lanes 1 & 4 : Anti-VRK1 antibody [5D1] - N-terminal (ab171933) at 1/100 dilution
    Lanes 2 & 5 : Anti-VRK1 antibody [5D1] - N-terminal (ab171933) at 1/500 dilution
    Lanes 3 & 6 : Anti-VRK1 antibody [5D1] - N-terminal (ab171933) at 1/1000 dilution

    Lanes 1-3 : HeLa cell extract (5x10e4 cells)
    Lanes 4-6 : U2OS cell extract (5x10e4 cells)

    Secondary
    All lanes : Alexa488 goat anti-mouse IgG

    Developed using the ECL technique.

    Predicted band size: 45 kDa

  • Western blot - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)
    Western blot - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)
    All lanes : Anti-VRK1 antibody [5D1] - N-terminal (ab171933) at 1/500 dilution

    Lane 1 : Extracts from TIG1 (5x10e4) cells: Luciferase RNAi (control)
    Lane 2 : Extracts from TIG1 (5x10e4) cells: VRK1-1 RNAi
    Lane 3 : Extracts from TIG1 (5x10e4) cells: VRK1-2 RNAi

    Developed using the ECL technique.

    Predicted band size: 45 kDa

  • Western blot - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)
    Western blot - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)
    All lanes : Anti-VRK1 antibody [5D1] - N-terminal (ab171933) at 1/500 dilution

    Lane 1 : Extracts from HeLa (5x10e4) cells: Luciferase RNAi (control)
    Lane 2 : Extracts from HeLa (5x10e4) cells: VRK1-1 RNAi
    Lane 3 : Extracts from HeLa (5x10e4) cells: VRK1-2 RNAi

    Developed using the ECL technique.

    Predicted band size: 45 kDa

  • Immunocytochemistry/ Immunofluorescence - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)
    Immunocytochemistry/ Immunofluorescence - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)

    Immunofluorescent analysis of paraformaldehyde-fixed metaphase HeLa cells labeling VRK1 with ab171933 at 1/100 dilution (center). DNA was stained with DAPI (left) and two images were merged (right; merge).

  • Immunocytochemistry/ Immunofluorescence - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)
    Immunocytochemistry/ Immunofluorescence - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)

    Immunofluorescent analysis of methanol-fixed interphase HeLa cells labeling VRK1 with ab171933 at 1/100 dilution (center). DNA was stained with DAPI (left) and two images were merged (right; merge).

  • Immunocytochemistry/ Immunofluorescence - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)
    Immunocytochemistry/ Immunofluorescence - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)

    Immunofluorescent analysis of methanol-fixed metaphase HeLa cells labeling VRK1 with ab171933 at 1/100 dilution (center). DNA was stained with DAPI (left) and two images were merged (right; merge).

    Metaphase cells. At metaphase, VRK1 dots were solely detected in nuclei.

  • Immunocytochemistry/ Immunofluorescence - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)
    Immunocytochemistry/ Immunofluorescence - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)

    Immunofluorescent analysis of formaldehyde-fixed interphase U-2 OS cells labeling VRK1 with ab171933 at 1/100 dilution (center). DNA was stained with DAPI (left) and two images were merged (right; merge).

  • Immunocytochemistry/ Immunofluorescence - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)
    Immunocytochemistry/ Immunofluorescence - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)

    Immunofluorescent analysis of formaldehyde-fixed metaphase U-2 OS cells labeling VRK1 with ab171933 at 1/100 dilution (center). DNA was stained with DAPI (left) and two images were merged (right; merge).

    Metaphase cells. At metaphase, VRK1 dots were solely detected in nuclei.

  • Immunocytochemistry/ Immunofluorescence - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)
    Immunocytochemistry/ Immunofluorescence - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)

    Immunofluorescent analysis of methanol-fixed interphase U-2 OS cells labeling VRK1 with ab171933 at 1/100 dilution (center). DNA was stained with DAPI (left) and two images were merged (right; merge).

  • Immunocytochemistry/ Immunofluorescence - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)
    Immunocytochemistry/ Immunofluorescence - Anti-VRK1 antibody [5D1] - N-terminal (ab171933)

    Immunofluorescent analysis of methanol-fixed metaphase U-2 OS cells labeling VRK1 with ab171933 at 1/100 dilution (center). DNA was stained with DAPI (left) and two images were merged (right; merge).

    Metaphase cells. At metaphase, VRK1 dots were solely detected in nuclei.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-VRK1 antibody [5D1] - N-terminal (ab171933)

  •  
  • Product image

    Anti-VRK1 antibody (ab211358)

    Applications: ICC/IF, IHC-P, WB

  •  
  • Product image

    Anti-VRK1 antibody (ab241103)

    Applications: IP, WB

  •  
  • Product image

    Anti-VRK1 antibody (ab241106)

    Applications: IP

  •  
  • Product image

    Anti-VRK1 antibody (ab228725)

    Applications: IHC-P, WB

Clear all

Recently viewed products

  •  
  • Product image

    Anti-NCE2/UBE2F antibody [EPR12932] - BSA and Azide free (ab240291)

  •  
  • Product image

    Anti-Carbonic Anhydrase 3/CA3 antibody [EPR13425] - BSA and Azide free (ab250486)

  •  
  • Product image

    Anti-PEF1 antibody [EPR9310] - BSA and Azide free (ab248836)

  •  
  • Product image

    Recombinant Human DAZL protein (ab112279)

  •  
  • Product image

    Anti-GPCR GPR55 antibody - N-terminal (ab229626)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.